Bibisha Baaniya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Bibisha Baaniya has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Sudha Agrawal
B. P. Koirala Institute of Health Sciences, Dharan, Nepal
2 shared publications Anubhav Poudel
Sukraraj Tropical and Infectious Disease Hospital, Kathmandu, Nepal
1 shared publicationAshmita Karki
Central Department of Public Health, Institute of Medicine, Kathmandu, Nepal
1 shared publicationBandana Bhatt
Department of Health Services, Ministry of Health and Population, Kathmandu, Nepal
1 shared publication- Bandana Neupane
Nepal Health Sector Support Programme (NHSSP)/DFID/Ministry of Health and Population, Kathmandu, Nepal
1 shared publication Govind Giri
Nobel College, Kathmandu, Nepal
1 shared publication
Latest Publications
- Open Access
- 5 May 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (5) , e70782
A Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts
Background and Aims: Intralesional immunotherapy is an upcoming method of wart treatment with fewer side effects and this study aims to assess and compare the efficacy of intralesional MMR vaccine and vitamin D3 in the treatment of nongenital warts. Methods: A comparative prospective study was done with a total of 61 patients divided into two groups. Thirty‐one patients were treated with intralesional MMR, while 30 patients received intralesional vitamin D3. In both groups, a maximum of five sessions were carried out every 3 weeks and follow‐up was done for 3 months. χ 2 , Fisher's exact, and multivariate analyses assessed variable relationships. Results: In the MMR group, 80.6% of patients achieved complete response, 6.5% had excellent response, 9.7% showed good response, and 3.2% had no response. Similarly, in the vitamin D3 group, 73.4% achieved complete response, 20.0% had excellent response, 3.3% showed good response and 3.3% had no response. The difference in response rates between the two groups was statistically insignificant. One patient (4.0%) in the MMR group and three patients (13.6%) in the vitamin D3 group experienced recurrence within 3 months of follow‐up, but this difference was not statistically significant. Both treatments were well tolerated. Pain was universal, while swelling (60%), hyperpigmentation (30%), and pruritus (16.7%) were more common with vitamin D3. In logistic regression analysis, pain duration was significantly higher in the Vitamin D group compared to the MMR group ( p < 0.001). Fever (MMR) and hypervitaminosis D3‐related fatigue (vitamin D3) were rare. No severe adverse events occurred. Conclusions: Both intralesional MMR and vitamin D3 showed positive response and were well tolerated and comfortable modalities for the treatment of warts. However, recurrence rate and side effects were higher with Vitamin D3 than MMR. Clinicaltrials.gov : NCT04428359.
- 5 May 2025
- Published by Wiley in Health Science Reports
- Vol. 8 (5) , e70782
Open AccessA Comparative Prospective Study to Assess Efficacy of Intralesional MMR (Measles, Mumps, Rubella) Vaccine and Intralesional Vitamin D3 in Treatment of Nongenital Warts
Background and Aims: Intralesional immunotherapy is an upcoming method of wart treatment with fewer side effects and this study aims to assess and compare the efficacy of intralesional MMR vaccine and vitamin D3 in the treatment of nongenital warts. Methods: A comparative prospective study was done with a total of 61 patients divided into two groups. Thirty‐one patients were treated with intralesional MMR, while 30 patients received intralesional vitamin D3. In both groups, a maximum of five sessions were carried out every 3 weeks and follow‐up was done for 3 months. χ 2 , Fisher's exact, and multivariate analyses assessed variable relationships. Results: In the MMR group, 80.6% of patients achieved complete response, 6.5% had excellent response, 9.7% showed good response, and 3.2% had no response. Similarly, in the vitamin D3 group, 73.4% achieved complete response, 20.0% had excellent response, 3.3% showed good response and 3.3% had no response. The difference in response rates between the two groups was statistically insignificant. One patient (4.0%) in the MMR group and three patients (13.6%) in the vitamin D3 group experienced recurrence within 3 months of follow‐up, but this difference was not statistically significant. Both treatments were well tolerated. Pain was universal, while swelling (60%), hyperpigmentation (30%), and pruritus (16.7%) were more common with vitamin D3. In logistic regression analysis, pain duration was significantly higher in the Vitamin D group compared to the MMR group ( p < 0.001). Fever (MMR) and hypervitaminosis D3‐related fatigue (vitamin D3) were rare. No severe adverse events occurred. Conclusions: Both intralesional MMR and vitamin D3 showed positive response and were well tolerated and comfortable modalities for the treatment of warts. However, recurrence rate and side effects were higher with Vitamin D3 than MMR. Clinicaltrials.gov : NCT04428359.
- Open Access
Intimate partner violence against married women of reproductive age in Nepal during the COVID-19 pandemic
- Open Access
- 31 December 2021
- Published by Nepal Journals Online (JOL) in Journal of BP Koirala Institute of Health Sciences
- Vol. 4 (2) , 45-48
Median Nail Dystrophy due to Habit Tic: A Case Report
Median dystrophy of nails may present with diagnostic difficulty. We present a case of a 30-year old male with multiple serial transverse ridges involving the median part of the bilateral great toe nails and the right thumb nail of approximately 10 years duration. On probing, the patient was found to have the habit of picking over the proximal nail folds. Habit of tic may not be noticed by the patient, however, may be the cause of dystrophy of nails.
- 31 December 2021
- Published by Nepal Journals Online (JOL) in Journal of BP Koirala Institute of Health Sciences
- Vol. 4 (2) , 45-48
Open AccessMedian Nail Dystrophy due to Habit Tic: A Case Report
Median dystrophy of nails may present with diagnostic difficulty. We present a case of a 30-year old male with multiple serial transverse ridges involving the median part of the bilateral great toe nails and the right thumb nail of approximately 10 years duration. On probing, the patient was found to have the habit of picking over the proximal nail folds. Habit of tic may not be noticed by the patient, however, may be the cause of dystrophy of nails.
- Open Access
- 23 October 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (10) , e04995
Exploring Pseudoainhum in Camisa syndrome
Immediate treatment of Camisa syndrome with systemic retinoids or surgery helps to prevent loss of digits. Here, we report a case of Camisa syndrome with pseudoainhum in the fifth toe leading to amputation as timely treatment was not sought.
- 23 October 2021
- Published by Wiley in Clinical Case Reports
- Vol. 9 (10) , e04995
Open AccessExploring Pseudoainhum in Camisa syndrome
Immediate treatment of Camisa syndrome with systemic retinoids or surgery helps to prevent loss of digits. Here, we report a case of Camisa syndrome with pseudoainhum in the fifth toe leading to amputation as timely treatment was not sought.
- Open Access
- 30 December 2020
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2020, 1-8
Kaposi Varicelliform Eruption in a Patient with Pemphigus Vulgaris: A Case Report and Review of the Literature
Haemorrhagic crusted lesions over pre-existing pemphigus vulgaris erosions should arouse suspicion of Kaposi varicelliform eruption (KVE). Immediate treatment with antivirals helps to prevent mortality and morbidities. Here, we report a case of a 67-year-old male who developed haemorrhagic crusted lesions on pre-existing pemphigus lesions during his hospital stay and obtained almost 90% resolution of cutaneous lesions of Pemphigus vulgaris as well as Kaposi varicelliform eruption within 2 weeks of acyclovir treatment along with the continuation of systemic steroids. We also highlight the review of the literature of other reported cases with its management.
- 30 December 2020
- Published by Wiley in Case Reports in Dermatological Medicine
- Vol. 2020, 1-8
Open AccessKaposi Varicelliform Eruption in a Patient with Pemphigus Vulgaris: A Case Report and Review of the Literature
Haemorrhagic crusted lesions over pre-existing pemphigus vulgaris erosions should arouse suspicion of Kaposi varicelliform eruption (KVE). Immediate treatment with antivirals helps to prevent mortality and morbidities. Here, we report a case of a 67-year-old male who developed haemorrhagic crusted lesions on pre-existing pemphigus lesions during his hospital stay and obtained almost 90% resolution of cutaneous lesions of Pemphigus vulgaris as well as Kaposi varicelliform eruption within 2 weeks of acyclovir treatment along with the continuation of systemic steroids. We also highlight the review of the literature of other reported cases with its management.